IP Library › Granted Patent US 12,186,526
Granted Patent B2
US 12,186,526 · App. 17/608,912 · Granted Jan 7, 2025

Drug solution administration unit, drug solution administration module, drug solution administration device, and medication management system

Inventor: Hidenori Nakamura (Yokohama, JP)
Assignee: atDose Co., Ltd.
A61M5/1409A61M5/16877A61M2205/3303
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,186,526
App. No.
17/608,912
Granted
Jan 7, 2025
Kind
B2
Abstract

A drug solution administration unit including a drug solution administration module having a first flow path unit, a second flow path unit, and a drive mechanism unit, and a drug solution administration device having a branch path and a main path. The first flow path unit includes an upstream side main body where a first flow path to store drive solution is formed, and the second flow path unit includes a downstream side main body where a second flow path to store drug solution is formed. The drive mechanism unit includes a pair of electrodes and a porous body sandwiched between the pair of electrodes, the drive mechanism unit has a connecting flow path connecting a downstream end of the first flow path and an upstream end of the second flow path.

Claims (24)

1. A drug solution administering unit, comprising:

a drug solution administration module comprising

a first flow path unit including an upstream side main body where a first flow path to store drive solution is formed,

a second flow path unit including a downstream side main body where a second flow path to store drug solution is formed, and

a drive mechanism unit including a pair of electrodes and a porous body sandwiched between the pair of electrodes, the drive mechanism unit having a connecting flow path connecting a downstream end of the first flow path and an upstream end of the second flow path; and

a drug solution administration device to which the drug solution administration module is mounted,

wherein the drug solution administration module has a drug solution connecting unit at a downstream end of the second flow path,

the drug solution administration device comprising:

a housing where a containment unit to store the drug solution administration module is formed,

inside of the housing, a branch path where the second flow path is connected, and

inside of the housing, a main path that is branched from a downstream side of the branch path and connected to an intravenous tube,

the main path connects an upstream connecting unit with a downstream connecting unit,

the upstream connecting unit connects the main path with the intravenous tube on an upstream side,

the downstream connecting unit connects the main path with the intravenous tube on a downstream side,

wherein the drug solution administration device has a flow path connecting unit at an upstream end of the branch path to which the drug solution connecting unit is connected.

2. The drug solution administration unit as claimed in claim 1 , wherein

the drug solution administration device further comprising a control unit being connected to the pair of electrodes for controlling an operation of the drive mechanism unit.

3. The drug solution administration unit as claimed in claim 2 , wherein

the housing has a plurality of the containment units to store a plurality of the drug solution administration modules.

4. The drug solution administration unit as claimed in claim 3 , comprising the plurality of the drug solution administration modules,

wherein the control unit controls operation of a respective drive mechanism unit of each drug solution administration module based on flow rate data indicating flow rate of drug solution administration by the plurality of the drug solution administration modules and administration data indicating a timing of the drug solution administration.

5. The drug solution administration unit as claimed in claim 1 ,

wherein the intravenous tube is configured to receive an infusion solution; and

wherein the drug solution administration module is configured to dispense the drug solution via the drug solution connecting unit and mix the drug solution with the infusion solution in the main path.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2021
From: NAKAMURA, HIDENORI
To: ATDOSE CO., LTD.
Reel/Frame 058056/0252 →
Priority Claims (1)
JP 2020-065560 · Apr 1, 2020 · national
Continuity (1)
Related Publication 20220313907A1 · Oct 6, 2022
References Cited (17)
US 10149938B2 · Murphy · 2018 [cited by examiner]
US 10359038B2 · van Boeyen · 2019 [cited by examiner]
US 20100191223A1 · Togawa · 2010 [cited by examiner]
US 20140088506A1 · Heller · 2014 [cited by examiner]
US 20210100948A1 · Hirafuji · 2021 [cited by applicant]
EP 0361688A1 · 1990 [cited by examiner]
EP 0543259A1 · 1993 [cited by applicant]
JP H05317421A · 1993 [cited by applicant]
JP 2008504794A · 2008 [cited by applicant]
WO WO8603418A1 · 1986 [cited by examiner]
WO 2009048144A1 · 2009 [cited by applicant]
WO 2015059766A1 · 2015 [cited by applicant]
WO 2018194041A1 · 2018 [cited by applicant]
Japanese Office Action issued on Apr. 22, 2020 of corresponding application No. 2020-065560; 6 pages. [cited by applicant]
International Search Report issued on Jun. 10, 2020 in corresponding International application No. PCT/JP2020/028950; 5 pages. [cited by applicant]
Extended European Search Report issued on Jan. 9, 2023, in corresponding European Application No. 20 92 9501.3, 8 pages. [cited by applicant]
India Examination Report issued on Mar. 27, 2023, in corresponding India Application No. 202017054642; 6 pages. [cited by applicant]